Andre Iffland is an experienced professional with a robust background in bioanalysis and pharmacokinetics, currently serving as Director and Head of Bioanalysis CRO Management at Vertex Pharmaceuticals since November 2013. Responsibilities include oversight of GLP Tox and clinical study outsourcing, project and alliance management, technical assessment of CROs, and ensuring compliance with industry best practices. Previous roles include Associate Director at Vertex, Associate Principal Scientist at Merck, and Senior Research Investigator at Bristol-Myers Squibb, with extensive expertise in bioanalytical method development and regulatory compliance. Iffland holds a Ph.D. in Molecular Evolution from EPFL and a Diploma in Natural Product Chemistry from Ruhr University Bochum.
This person is not in the org chart
This person is not in any teams
This person is not in any offices